AMAG Pharmaceuticals, Inc. Appoints Michael Porter as Chief Executive Officer
November 17, 2020 at 06:02 am
As previously disclosed, on October 1, 2020, AMAG Pharmaceuticals, Inc. (‘AMAG’), entered into an Agreement and Plan of Merger (the ‘Merger Agreement’) with Covis Group S.à r.l. (‘Covis’), Covis Mergerco Inc. and an indirect wholly owned subsidiary of Covis (‘Merger Sub’), and solely with respect to certain sections therein, Covis Finco S.à r.l. (‘Covis Finco’). Immediately upon the Merger, Michael Porter assumed the role of Chief Executive Officer of AMAG.